These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 18403106)
1. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106 [TBL] [Abstract][Full Text] [Related]
2. Tumor risk in disorders of sex development (DSD). Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493 [TBL] [Abstract][Full Text] [Related]
3. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162 [TBL] [Abstract][Full Text] [Related]
4. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118 [TBL] [Abstract][Full Text] [Related]
5. Tumor risk in disorders of sex development. Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977 [TBL] [Abstract][Full Text] [Related]
6. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. Looijenga LH J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916 [TBL] [Abstract][Full Text] [Related]
7. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410 [TBL] [Abstract][Full Text] [Related]
8. Gonadal tumours and DSD. Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153 [TBL] [Abstract][Full Text] [Related]
9. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846 [TBL] [Abstract][Full Text] [Related]
10. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133 [TBL] [Abstract][Full Text] [Related]
11. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY. Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444 [TBL] [Abstract][Full Text] [Related]
12. Gonadal development and tumor formation at the crossroads of male and female sex determination. Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949 [TBL] [Abstract][Full Text] [Related]
13. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Rajpert-De Meyts E Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528 [TBL] [Abstract][Full Text] [Related]
14. Stem cell factor as a novel diagnostic marker for early malignant germ cells. Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970 [TBL] [Abstract][Full Text] [Related]
15. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392 [TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607 [TBL] [Abstract][Full Text] [Related]
17. From gonocytes to testicular cancer: the role of impaired gonadal development. Rajpert-de Meyts E; Hoei-Hansen CE Ann N Y Acad Sci; 2007 Dec; 1120():168-80. PubMed ID: 18184914 [TBL] [Abstract][Full Text] [Related]
18. Tumor risk and clinical follow-up in patients with disorders of sex development. Cools M; Looijenga LH Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509 [TBL] [Abstract][Full Text] [Related]
19. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Li Y; Vilain E; Conte F; Rajpert-De Meyts E; Lau YF Urol Oncol; 2007; 25(2):141-6. PubMed ID: 17349529 [TBL] [Abstract][Full Text] [Related]
20. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. Wünsch L; Holterhus PM; Wessel L; Hiort O BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]